Mapping the Epidemiology of Kaposi Sarcoma and Non‐Hodgkin Lymphoma Among Children in Sub‐Saharan Africa: A Review

CA Rees, EM Keating, H Lukolyo… - Pediatric blood & …, 2016 - Wiley Online Library
CA Rees, EM Keating, H Lukolyo, HE Danysh, ME Scheurer, PS Mehta, J Lubega, JS Slone
Pediatric blood & cancer, 2016Wiley Online Library
Children with human immunodeficiency virus (HIV) have an increased risk of developing
Kaposi Sarcoma (KS) and non‐Hodgkin lymphoma (NHL) compared to HIV‐negative
children. We compiled currently published epidemiologic data on KS and NHL among
children in sub‐Saharan Africa (SSA). Among countries with available data, the median
incidence of KS was 2.05/100,000 in the general pediatric population and 67.35/100,000
among HIV‐infected children. The median incidence of NHL was 1.98/100,000 among the …
Children with human immunodeficiency virus (HIV) have an increased risk of developing Kaposi Sarcoma (KS) and non‐Hodgkin lymphoma (NHL) compared to HIV‐negative children. We compiled currently published epidemiologic data on KS and NHL among children in sub‐Saharan Africa (SSA). Among countries with available data, the median incidence of KS was 2.05/100,000 in the general pediatric population and 67.35/100,000 among HIV‐infected children. The median incidence of NHL was 1.98/100,000 among the general pediatric population, while data on NHL incidence among HIV‐infected children were lacking. Larger regional studies are needed to better address the dearth of epidemiologic information on pediatric KS and NHL in SSA.
Wiley Online Library